{"id":"https://openalex.org/W2329997149","doi":"https://doi.org/10.1158/1538-7445.am2011-3513","title":"Abstract 3513: MK-2206 combined with ridaforolimus or topoisomerase inhibitors synergistically impede the growth of sarcoma cells","display_name":"Abstract 3513: MK-2206 combined with ridaforolimus or topoisomerase inhibitors synergistically impede the growth of sarcoma cells","publication_year":2011,"publication_date":"2011-04-01","ids":{"openalex":"https://openalex.org/W2329997149","doi":"https://doi.org/10.1158/1538-7445.am2011-3513","mag":"2329997149"},"language":"en","primary_location":{"id":"doi:10.1158/1538-7445.am2011-3513","doi":"https://doi.org/10.1158/1538-7445.am2011-3513","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2011-3513","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5036862186","display_name":"Christopher L. Cubitt","orcid":"https://orcid.org/0000-0001-6343-7451","observed_orcids":["https://orcid.org/0000-0001-6343-7451"]},"institutions":[{"id":"https://openalex.org/I3019308854","display_name":"Moffitt Cancer Center","ror":"https://ror.org/01xf75524","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I3019308854"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Christopher L. Cubitt","raw_affiliation_strings":["1Moffitt Cancer Center & Research Institute, Tampa, FL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Moffitt Cancer Center & Research Institute, Tampa, FL","institution_ids":["https://openalex.org/I3019308854"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5008113532","display_name":"Jillaina L. Menth","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I3019308854","display_name":"Moffitt Cancer Center","ror":"https://ror.org/01xf75524","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I3019308854"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jillaina L. Menth","raw_affiliation_strings":["1Moffitt Cancer Center & Research Institute, Tampa, FL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Moffitt Cancer Center & Research Institute, Tampa, FL","institution_ids":["https://openalex.org/I3019308854"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5035721135","display_name":"Jana L. Dawson","orcid":"https://orcid.org/0000-0002-4901-0897","observed_orcids":["https://orcid.org/0000-0002-4901-0897"]},"institutions":[{"id":"https://openalex.org/I3019308854","display_name":"Moffitt Cancer Center","ror":"https://ror.org/01xf75524","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I3019308854"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jana L. Dawson","raw_affiliation_strings":["1Moffitt Cancer Center & Research Institute, Tampa, FL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Moffitt Cancer Center & Research Institute, Tampa, FL","institution_ids":["https://openalex.org/I3019308854"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5029966550","display_name":"Damon R. Reed","orcid":"https://orcid.org/0000-0002-8238-2465","observed_orcids":["https://orcid.org/0000-0002-8238-2465"]},"institutions":[{"id":"https://openalex.org/I3019308854","display_name":"Moffitt Cancer Center","ror":"https://ror.org/01xf75524","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I3019308854"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Damon R. Reed","raw_affiliation_strings":["1Moffitt Cancer Center & Research Institute, Tampa, FL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Moffitt Cancer Center & Research Institute, Tampa, FL","institution_ids":["https://openalex.org/I3019308854"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5102841436","display_name":"Daniel M. Sullivan","orcid":"https://orcid.org/0009-0003-0951-9781","observed_orcids":["https://orcid.org/0009-0003-0951-9781","https://orcid.org/0000-0002-2183-1773"]},"institutions":[{"id":"https://openalex.org/I3019308854","display_name":"Moffitt Cancer Center","ror":"https://ror.org/01xf75524","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I3019308854"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Daniel M. Sullivan","raw_affiliation_strings":["1Moffitt Cancer Center & Research Institute, Tampa, FL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Moffitt Cancer Center & Research Institute, Tampa, FL","institution_ids":["https://openalex.org/I3019308854"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I3019308854"],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"71","issue":"8_Supplement","first_page":"3513","last_page":"3513"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10253","display_name":"Sarcoma Diagnosis and Treatment","score":0.888700008392334,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10253","display_name":"Sarcoma Diagnosis and Treatment","score":0.888700008392334,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10952","display_name":"PI3K/AKT/mTOR signaling in cancer","score":0.10360000282526016,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12820","display_name":"Chromatin Remodeling and Cancer","score":0.0006000000284984708,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/ridaforolimus","display_name":"ridaforolimus","score":0.8769999742507935},{"id":"https://openalex.org/keywords/topoisomerase-inhibitors","display_name":"topoisomerase inhibitors","score":0.9110000133514404},{"id":"https://openalex.org/keywords/etoposide","display_name":"etoposide","score":0.902999997138977},{"id":"https://openalex.org/keywords/topotecan","display_name":"topotecan","score":0.8320000171661377},{"id":"https://openalex.org/keywords/cisplatin","display_name":"cisplatin","score":0.9990000128746033},{"id":"https://openalex.org/keywords/sarcoma","display_name":"sarcoma","score":0.8809999823570251},{"id":"https://openalex.org/keywords/drug-synergy","display_name":"drug synergy","score":0.652999997138977},{"id":"https://openalex.org/keywords/akt-inhibitors","display_name":"AKT inhibitors","score":0.8270000219345093},{"id":"https://openalex.org/keywords/mtor-inhibitors","display_name":"mTOR inhibitors","score":0.9959999918937683},{"id":"https://openalex.org/keywords/rhabdomyosarcoma","display_name":"rhabdomyosarcoma","score":0.8650000095367432},{"id":"https://openalex.org/keywords/osteosarcoma","display_name":"osteosarcoma","score":0.9639999866485596},{"id":"https://openalex.org/keywords/ewing-sarcoma","display_name":"Ewing sarcoma","score":0.972000002861023},{"id":"https://openalex.org/keywords/leiomyosarcoma","display_name":"leiomyosarcoma","score":0.8840000033378601},{"id":"https://openalex.org/keywords/liposarcoma","display_name":"liposarcoma","score":0.9120000004768372},{"id":"https://openalex.org/keywords/fibrosarcoma","display_name":"fibrosarcoma","score":0.9800000190734863}],"concepts":[{"id":"https://openalex.org/C2778119113","wikidata":"https://www.wikidata.org/wiki/Q418817","display_name":"Etoposide","level":3,"score":0.70909583568573},{"id":"https://openalex.org/C2781209748","wikidata":"https://www.wikidata.org/wiki/Q419953","display_name":"Topotecan","level":3,"score":0.6387329697608948},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.6348378658294678},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5290390849113464},{"id":"https://openalex.org/C53227056","wikidata":"https://www.wikidata.org/wiki/Q189152","display_name":"Viability assay","level":3,"score":0.41572511196136475},{"id":"https://openalex.org/C147897179","wikidata":"https://www.wikidata.org/wiki/Q407828","display_name":"Topoisomerase","level":3,"score":0.4102635681629181},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.3060518801212311},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.26949623227119446},{"id":"https://openalex.org/C190283241","wikidata":"https://www.wikidata.org/wiki/Q14599311","display_name":"Apoptosis","level":2,"score":0.24485817551612854},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.24358657002449036},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.2103542983531952},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.11196291446685791}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1538-7445.am2011-3513","doi":"https://doi.org/10.1158/1538-7445.am2011-3513","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2011-3513","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9476000070571899,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2560371191","https://openalex.org/W2320741374","https://openalex.org/W2024804801","https://openalex.org/W1986350942","https://openalex.org/W2120873267","https://openalex.org/W1999955449","https://openalex.org/W2015391596","https://openalex.org/W2056445663","https://openalex.org/W2094572702","https://openalex.org/W4367053403"],"abstract_inverted_index":{"Abstract":[0],"The":[1,25,102,122,151,261],"number":[2],"of":[3,10,22,27,35,54,61,86,138,170,191,210,247,255,263,304,309],"effective":[4,281],"drugs":[5],"available":[6],"for":[7,105,126,156,230,284,313],"the":[8,33,66,135,245,253,292,305,310],"treatment":[9,282],"soft":[11],"tissue":[12],"and":[13,74,89,165,193,201,213,234,252],"bone":[14],"sarcomas":[15,62],"is":[16],"limited":[17],"to":[18,31,83,113,118,130,180,217,243],"a":[19,52,97,215,268,273],"small":[20],"group":[21],"antineoplastic":[23],"agents.":[24],"goal":[26],"this":[28,264],"study":[29,265],"was":[30,128,148,177,224,289],"determine":[32,134],"effectiveness":[34],"MK-2206":[36,87,106,157,181,231,235,248,269,274],"(Akt":[37],"inhibitor)":[38],"when":[39],"used":[40],"in":[41,51,65,90,178,221,226],"combination":[42,91,203,277],"with":[43,159,168,187],"Ridaforolimus":[44,108,160,233,271],"(mTor":[45],"inhibitor),":[46],"Cisplatin,":[47],"Topotecan":[48,186],"or":[49,107,116,161,185,272],"Etoposide":[50,127,162,237,276],"panel":[53],"ten":[55],"cell":[56,78,222,228],"lines.":[57],"Six":[58],"different":[59],"types":[60],"are":[63,241],"represented":[64],"panel,":[67],"including":[68],"rhabdo-,":[69],"osteo-,":[70],"Ewing,":[71],"leiomyo-,":[72],"lipo-":[73],"fibrosarcomas.":[75],"Cell":[76],"Titer-Blue":[77],"viability":[79,223],"experiments":[80,240],"were":[81,163],"performed":[82,149],"test":[84],"dilutions":[85],"alone":[88,109],"at":[92],"various":[93],"molar":[94],"ratios":[95],"over":[96,142],"72":[98],"hour":[99],"time":[100],"period.":[101],"observed":[103,123,225],"IC50s":[104],"ranged":[110],"from":[111],"4.2":[112],"12.9":[114],"\u00b5M":[115],"23.7":[117],"62.3":[119],"\u00b5M,":[120],"respectively.":[121],"IC50":[124],"range":[125],"0.5":[129],"7.5":[131],"\u00b5M.":[132],"To":[133],"relative":[136],"potentiation":[137],"drug":[139,256],"combinations,":[140],"Excess":[141,153],"Highest":[143],"Single":[144],"Agent":[145],"(HSA)":[146],"analysis":[147],"(Table).":[150],"average":[152,188],"HSA":[154,189],"score":[155],"combinations":[158,182,249],"0.17":[164],"0.15":[166],"respectively":[167],"levels":[169,209],"significance":[171],"(p":[172],"value)":[173],"<":[174],"0.032.":[175],"This":[176,287],"contrast":[179],"containing":[183],"Cisplatin":[184],"scores":[190],"0.084":[192],"0.085,":[194],"respectively,":[195],"indicating":[196],"less":[197],"potentiation.":[198],"Using":[199],"Chou":[200],"Talalay":[202],"index":[204],"(CI)":[205],"analyses":[206],"(effective":[207],"dose":[208],"0.7,":[211],"0.9":[212],"0.95),":[214],"synergistic":[216,219],"strongly":[218],"reduction":[220],"5":[227],"lines":[229],"plus":[232,236,270,275],"combinations.":[238],"Ongoing":[239],"underway":[242],"identify":[244],"effects":[246],"on":[250,258],"apoptosis":[251],"effect":[254],"sequencing":[257],"growth":[259],"inhibition.":[260],"results":[262],"indicate":[266],"that":[267],"may":[278],"be":[279],"an":[280],"regimen":[283],"sarcoma":[285],"patients.":[286],"work":[288],"funded":[290],"by":[291],"Pediatric":[293],"Cancer":[294,314,324],"Foundation.":[295],"Citation":[296],"Format:":[297],"{Authors}.":[298],"{Abstract":[299],"title}":[300],"[abstract].":[301],"In:":[302],"Proceedings":[303],"102nd":[306],"Annual":[307],"Meeting":[308],"American":[311],"Association":[312],"Research;":[315],"2011":[316],"Apr":[317],"2-6;":[318],"Orlando,":[319],"FL.":[320],"Philadelphia":[321],"(PA):":[322],"AACR;":[323],"Res":[325],"2011;71(8":[326],"Suppl):Abstract":[327],"nr":[328],"3513.":[329],"doi:10.1158/1538-7445.AM2011-3513":[330]},"counts_by_year":[],"updated_date":"2026-10-16T09:59:22.235173","created_date":"2016-06-24T00:00:00"}